HCPCS codes

63646 HCPCS codes with hospital pricing data in the network.

Sorted by number of hospitals reporting each code, most first.

• HCPCS S9024 — Paranasal sinus ultrasound (48 hospitals)
• HCPCS A2036 — Cohealyx collagen dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS A2038 — Marigen pacto, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS A2039 — Innovamatrix fd, per square centimeter (add-on, list separately in addition to primary procedure) (48 hospitals)
• HCPCS A9616 — Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie (48 hospitals)
• HCPCS C8006 — Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed (48 hospitals)
• HCPCS C9307 — Injection, linvoseltamab-gcpt, 1 mg (48 hospitals)
• HCPCS C9308 — Injection, carboplatin (avyxa), 1 mg (48 hospitals)
• HCPCS C9794 — Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., mo (48 hospitals)
• HCPCS C9795 — Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, e (48 hospitals)
• HCPCS G0571 — Intraoperative nerve(s) cryoablation for post-surgical pain relief (list separately in addition to code for primary service) (48 hospitals)
• HCPCS H0003 — Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs (48 hospitals)
• HCPCS H0008 — Alcohol and/or drug services; sub-acute detoxification (hospital inpatient) (48 hospitals)
• HCPCS H0009 — Alcohol and/or drug services; acute detoxification (hospital inpatient) (48 hospitals)
• HCPCS H0010 — Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient) (48 hospitals)
• HCPCS H0011 — Alcohol and/or drug services; acute detoxification (residential addiction program inpatient) (48 hospitals)
• HCPCS H2036 — Alcohol and/or other drug treatment program, per diem (48 hospitals)
• HCPCS J0013 — Esketamine, nasal spray, 1 mg (48 hospitals)
• HCPCS J0163 — Injection, epinephrine in sodium chloride (endo), 0.1 mg (48 hospitals)
• HCPCS J0164 — Injection, epinephrine in sodium chloride (baxter), 0.1 mg (48 hospitals)
• HCPCS J0458 — Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg) (48 hospitals)
• HCPCS J0582 — Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg (48 hospitals)
• HCPCS J0614 — Injection, treosulfan, 50 mg (48 hospitals)
• HCPCS J0681 — Injection, ceftobiprole medocaril sodium, 3 mg (48 hospitals)
• HCPCS J0738 — Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) (48 hospitals)
• HCPCS J0752 — Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) (48 hospitals)
• HCPCS J1073 — Testosterone pellet, implant, 75 mg (48 hospitals)
• HCPCS J1370 — Injection, esomeprazole sodium, 1 mg (48 hospitals)
• HCPCS J1612 — Injection, glucagon (gvoke), 0.01 mg (48 hospitals)
• HCPCS J1737 — Injection, meloxicam (azurity), 1 mg (48 hospitals)
• HCPCS J1809 — Injection, fosdenopterin, 0.1 mg (48 hospitals)
• HCPCS J1837 — Injection, posaconazole, 1 mg (48 hospitals)
• HCPCS J2291 — Injection, nafcillin sodium (baxter), 20 mg (48 hospitals)
• HCPCS J2596 — Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit (48 hospitals)
• HCPCS J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg (48 hospitals)
• HCPCS J3387 — Injection, elivaldogene autotemcel, per treatment (48 hospitals)
• HCPCS J3389 — Topical administration, prademagene zamikeracel, per treatment (48 hospitals)
• HCPCS J3402 — Injection, remestemcel-l-rknd, per therapeutic dose (48 hospitals)
• HCPCS J3403 — Revakinagene taroretcel-lwey, per implant (48 hospitals)
• HCPCS J7173 — Injection, concizumab-mtci, 0.5 mg (48 hospitals)
• HCPCS J7174 — Injection, fitusiran, 0.04 mg (48 hospitals)
• HCPCS J7299 — Intrauterine copper contraceptive (miudella) (48 hospitals)
• HCPCS J7356 — Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg (48 hospitals)
• HCPCS J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram (48 hospitals)
• HCPCS J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg (48 hospitals)
• HCPCS J7634 — Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram (48 hospitals)
• HCPCS J7647 — Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram (48 hospitals)
• HCPCS J7657 — Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram (48 hospitals)
• HCPCS J7667 — Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams (48 hospitals)
• HCPCS J7676 — Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg (48 hospitals)